|
Schedule - EU 28: science, medicines, health
|
(English only)
|
21/05/2013
|
|
|
Programme - EU 28: science, medicines, health
|
(English only)
|
06/02/2013
|
21/05/2013
|
|
Presentation - EU legislative and policy developments in the medicinal products area (Stefano Soro)
|
(English only)
|
21/05/2013
|
|
|
Presentation - HALMED achievements during IPA project (Viola Sarinic)
|
(English only)
|
21/05/2013
|
|
|
Presentation - CP extension to Croatia: Industry perspective (Mislav Vučić)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Croatia - Decision making phasing-in (Tony Humphreys)
|
(English only)
|
21/05/2013
|
|
|
Presentation - API – The new approach for third countries: What are the consequences? Should we expect shortage of medicinal products in the country? - Perspectives from an acceding country (Stefano Soro)
|
(English only)
|
21/05/2013
|
|
|
Presentation - API – The new approach for third countries: Perspectives from an acceding country (Anita Sučić)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Pre-accession challenges: HALMED perspective (Maja Lovrek)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Pharmacovigilance pre-accession challenges: Industry view (Tatjana Đuretek)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Pre-accession regulatory challenges: Industry view (V. Kartelo)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Regulatory pathways to new medicines (Tony Humphreys)
|
(English only)
|
21/05/2013
|
|
|
Presentation - MRP and DCP step by step instructions how to apply and how the procedures are conducted (Peter Bachmann)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Update on implementation of Pharmacovigilance legislation (Franck Diafouka)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Good Vigilance Practice Modules I-IV Pharmacovigilance quality assurance and control (Fergus Sweeney)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Overview of GVP modules V (risk management systems), VIII (post-authorisation safety studies) and ENCePP (Thomas Goedecke)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Overview of GVP Modules on ADR, PSURs, Signal Management and Additional Monitoring (Mick Foy)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Reporting of adverse drug reactions by patients – Croatian experience (Marina Giusti)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Patient ADR Reporting – UK view (Mick Foy)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Patients reporting in Croatia - Patients association’s experiences (Jurica Ester)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Supervision of manufacturers: What is expected of National Competent Authorities? (Fergus Sweeney)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Cooperation between HALMED and GMP Inspectorate in supervision of manufacturers: Croatia’s experience so far (Ana Boban)
|
(English only)
|
21/05/2013
|
|
|
Presentation - What do manufacturers and importers have to do to prepare for EU membership? - Pharmaceutical regulatory affairs consulting and education (Vesna Koblar)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Practical implementation of the falsified medicines directive (Belén Romero)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Going digital: General aspects (Klaus Menges, Olivier Simoen)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Going digital: Current initiatives (Andrea Johnson, Olivier Simoen)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Practical aspects of working electronically in the network: Croatian experience (Dubravka Sudić)
|
(English only)
|
21/05/2013
|
|
|
Presentation - Practical aspects of working electronically in the network: Federal agency for medicines and health
products (Pieter Vankeerberghen)
|
(English only)
|
21/05/2013
|
|